JP2022512935A5 - - Google Patents

Info

Publication number
JP2022512935A5
JP2022512935A5 JP2021524303A JP2021524303A JP2022512935A5 JP 2022512935 A5 JP2022512935 A5 JP 2022512935A5 JP 2021524303 A JP2021524303 A JP 2021524303A JP 2021524303 A JP2021524303 A JP 2021524303A JP 2022512935 A5 JP2022512935 A5 JP 2022512935A5
Authority
JP
Japan
Prior art keywords
formula
compound
forming
reacted
steps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512935A (ja
JP7437395B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060677 external-priority patent/WO2020102051A1/en
Publication of JP2022512935A publication Critical patent/JP2022512935A/ja
Publication of JP2022512935A5 publication Critical patent/JP2022512935A5/ja
Priority to JP2024018294A priority Critical patent/JP2024056819A/ja
Application granted granted Critical
Publication of JP7437395B2 publication Critical patent/JP7437395B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021524303A 2018-11-12 2019-11-11 細胞傷害性ベンゾジアゼピン誘導体の調製方法 Active JP7437395B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024018294A JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862758814P 2018-11-12 2018-11-12
US62/758,814 2018-11-12
PCT/US2019/060677 WO2020102051A1 (en) 2018-11-12 2019-11-11 Methods of preparing cytotoxic benzodiazepine derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024018294A Division JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Publications (3)

Publication Number Publication Date
JP2022512935A JP2022512935A (ja) 2022-02-07
JP2022512935A5 true JP2022512935A5 (enExample) 2022-11-17
JP7437395B2 JP7437395B2 (ja) 2024-02-22

Family

ID=68835289

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021524303A Active JP7437395B2 (ja) 2018-11-12 2019-11-11 細胞傷害性ベンゾジアゼピン誘導体の調製方法
JP2024018294A Withdrawn JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024018294A Withdrawn JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Country Status (12)

Country Link
US (3) US10851117B2 (enExample)
EP (2) EP3880681B1 (enExample)
JP (2) JP7437395B2 (enExample)
KR (1) KR20210098470A (enExample)
CN (2) CN112996792B (enExample)
AU (1) AU2019379104A1 (enExample)
CA (1) CA3119358A1 (enExample)
IL (1) IL283045A (enExample)
MA (1) MA54228A (enExample)
SG (1) SG11202104360YA (enExample)
TW (1) TW202033530A (enExample)
WO (1) WO2020102051A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL305224B2 (en) * 2017-04-20 2024-09-01 Immunogen Inc Methods of preparing indolinobenzodiazepine derivatives
MA54228A (fr) 2018-11-12 2021-09-22 Immunogen Inc Procédés de préparation de dérivés de benzodiazépine cytotoxiques
EP4548932A1 (en) 2022-06-30 2025-05-07 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902707A (en) * 1985-04-30 1990-02-20 Eli Lilly And Company Bicyclic pyrazolidinones, compositions and use
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
CN102050824A (zh) * 2009-11-04 2011-05-11 上海阳帆医药科技有限公司 哌嗪并三唑衍生物
JP5826863B2 (ja) 2011-02-15 2015-12-02 イミュノジェン・インコーポレーテッド 細胞傷害性ベンゾジアゼピン誘導体
RU2539658C1 (ru) 2013-12-10 2015-01-20 Федеральное государственное казенное учреждение "33 Центральный научно-исследовательский испытательный институт Министерства обороны Российской Федерации" Способ получения бензилхлорида
SMT202000614T1 (it) * 2015-06-29 2021-01-05 Immunogen Inc Coniugati di anticorpi ingegnerizzati con cisteina
AU2016285552B2 (en) * 2015-06-29 2022-10-13 Immunogen, Inc. Anti-CD123 antibodies and conjugates and derivatives thereof
EP3325482B1 (en) * 2015-07-21 2020-06-24 ImmunoGen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
US20170189548A1 (en) * 2015-11-25 2017-07-06 Immunogen, Inc. Pharmaceutical formulations and methods of use thereof
EP4148044A1 (en) * 2017-01-25 2023-03-15 ImmunoGen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
US11793885B2 (en) * 2017-12-28 2023-10-24 Immunogen, Inc. Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders
MA54228A (fr) 2018-11-12 2021-09-22 Immunogen Inc Procédés de préparation de dérivés de benzodiazépine cytotoxiques

Similar Documents

Publication Publication Date Title
JP2022512935A5 (enExample)
JP2018526340A5 (enExample)
CN103772624B (zh) 一种早强型聚羧酸盐混凝土减水剂及其制备方法
CN1028525C (zh) 制备内烯烃磺酸盐的方法
JP2021063097A5 (enExample)
CN110563660B (zh) 一种减少1,2,4-三氮唑烷基化反应过程中1,3,4-三氮唑取代物的方法
JP2018522018A5 (enExample)
JP2009533369A5 (enExample)
CN1069637C (zh) 吡唑及其衍生物的制备方法
JP2018528182A5 (enExample)
JP2018524387A5 (enExample)
CN104031216A (zh) 一种聚醚-酰胺型聚羧酸高效减水剂及其制备方法
CN114315655A (zh) 一种吸电子基团的不饱和烷烃的磺化方法
CN108191288A (zh) 一种高保坍型聚羧酸高性能减水剂及其制备方法
CN114196005A (zh) N,n-二取代基氨基磺酸化合物的制备方法及其应用
JPS5975902A (ja) ヒドロキシエチルセルロ−スの製造法
JPH10330401A (ja) 新規多糖誘導体及びその製造方法
CN107892699B (zh) 一种吡啶-4-硼酸的合成工艺
RU2024102597A (ru) Способы получения цитотоксических производных бензодиазепина
RU2021114996A (ru) Способы получения цитотоксических производных бензодиазепина
CN109503552A (zh) 一种合成阿西替尼的方法
CN108558710A (zh) 一种n,n-二丁基间氨基苯酚的制备方法
CN115536677A (zh) 零维四核金属卤化物团簇材料、团簇发光材料及其制备方法与应用
CN106748835A (zh) 一种盐酸肾上腺酮的制备方法
CN101983958B (zh) 一种2-重氮乙酰乙酸对硝基苄酯的制备方法